KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer
about
KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
KDM6B Counteracts EZH2-Mediate ...... tor Treatment in Breast Cancer
@en
type
label
KDM6B Counteracts EZH2-Mediate ...... tor Treatment in Breast Cancer
@en
prefLabel
KDM6B Counteracts EZH2-Mediate ...... tor Treatment in Breast Cancer
@en
P2093
P1476
KDM6B Counteracts EZH2-Mediate ...... tor Treatment in Breast Cancer
@en
P2093
Dave S B Hoon
Diego Marzese
Keng Gat Lim
Puay Leng Lee
Yufeng Chen
P304
P356
10.1158/1535-7163.MCT-17-0802
P577
2018-06-20T00:00:00Z